Quarterly report pursuant to Section 13 or 15(d)

Interim Consolidated Balance Sheets (unaudited)

v3.20.1
Interim Consolidated Balance Sheets (unaudited) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Current assets    
Cash and cash equivalents $ 65,292 $ 72,256
Restricted cash 149 154
Short-term deposits 10,052 10,003
Related parties 50
Other current assets 1,680 2,068
Total current assets 77,173 84,531
Lease deposit 5 5
Property and equipment, net 2,039 1,881
In-process research and development ("R&D") 4,177 4,556
Operating lease right-of-use asset 1,066 1,148
Total non-current assets 7,287 7,590
Total asset 84,460 92,121
Current liabilities    
Trade account payables 1,340 3,253
Other account payables 2,380 2,596
Current portion of lease liabilities 361 375
Total current liabilities 4,081 6,224
Non-current liabilities    
Lease liabilities - net of current portion 740 856
Contingent liabilities 641 585
Total non-current liabilities 1,381 1,441
Commitments and Contingent Liabilities  
Shareholders' equity    
Common stock, $0.0001 par value ("Ordinary Shares"); Authorized -60,000,000 shares as of March 31, 2020 and December 31, 2019. Issued - 22,925,860 as of March 31, 2020 and December 31, 2019. Outstanding - 22,920,160 shares as of March 31, 2020 and 22,862,835 as of December 31, 2019. 2 2
Additional paid in capital 127,069 126,626
Accumulated deficit (48,073) (42,172)
Total shareholders' equity 78,998 84,456
Total liabilities and shareholders' equity $ 84,460 $ 92,121